Detalhe da pesquisa
1.
Management of Persistent SARS-CoV-2 Infection in Patients with Follicular Lymphoma.
Acta Haematol
; 145(4): 384-393, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34839289
2.
Guidelines for diagnosis, prevention and management of central nervous system involvement in diffuse large B-cell lymphoma patients by the Spanish Lymphoma Group (GELTAMO).
Haematologica
; 102(2): 235-245, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27846613
3.
Contribution of cerebrospinal fluid sCD19 levels to the detection of CNS lymphoma and its impact on disease outcome.
Blood
; 123(12): 1864-9, 2014 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-24501214
4.
GEM2005 trial update comparing VMP/VTP as induction in elderly multiple myeloma patients: do we still need alkylators?
Blood
; 124(12): 1887-93, 2014 Sep 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-25102853
5.
Recommendations on the clinical use of bendamustine in lymphoproliferative syndromes and multiple myeloma.
Eur J Haematol
; 96(5): 532-40, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26179864
6.
Long-Term Follow-Up of a Phase II Trial of Six Cycles of Dose-Dense R-CHOP-14 for First-Line Treatment of Diffuse Large B-Cell Lymphoma in Young and Elderly Patients.
Acta Haematol
; 136(2): 76-84, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27188649
7.
Maintenance therapy with bortezomib plus thalidomide or bortezomib plus prednisone in elderly multiple myeloma patients included in the GEM2005MAS65 trial.
Blood
; 120(13): 2581-8, 2012 Sep 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-22889759
8.
Outcome according to cytogenetic abnormalities and DNA ploidy in myeloma patients receiving short induction with weekly bortezomib followed by maintenance.
Blood
; 118(17): 4547-53, 2011 Oct 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-21900193
9.
Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple myeloma: a randomised trial.
Lancet Oncol
; 11(10): 934-41, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20739218
10.
R-COMP versus R-CHOP as first-line therapy for diffuse large B-cell lymphoma in patients ≥60 years: Results of a randomized phase 2 study from the Spanish GELTAMO group.
Cancer Med
; 10(4): 1314-1326, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33492774
11.
Risk Factors and Mortality of COVID-19 in Patients With Lymphoma: A Multicenter Study.
Hemasphere
; 5(3): e538, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33604516
12.
Rituximab is an effective and safe therapeutic alternative in adults with refractory and severe autoimmune hemolytic anemia.
Ann Hematol
; 89(11): 1073-80, 2010 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-20526716
13.
Clinical significance of occult cerebrospinal fluid involvement assessed by flow cytometry in non-Hodgkin's lymphoma patients at high risk of central nervous system disease in the rituximab era.
Eur J Haematol
; 85(4): 321-8, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20528905
14.
Response-adapted treatment with rituximab, bendamustine, mitoxantrone, and dexamethasone followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma after first-line immunochemotherapy: Results of the RBMDGELTAMO08 phase II trial.
Cancer Med
; 8(16): 6955-6966, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31573746
15.
Prognostic utility of serum free light chain ratios and heavy-light chain ratios in multiple myeloma in three PETHEMA/GEM phase III clinical trials.
PLoS One
; 13(9): e0203392, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30192814
16.
How to facilitate early diagnosis of CNS involvement in malignant lymphoma.
Expert Rev Hematol
; 9(11): 1081-1091, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27677656
17.
Evaluation of clinical and biological prognostic factors in relapsed or refractory diffuse large B-cell lymphoma patients after previous treatment with rituximab and chemotherapy: results of the PRO-R-IPI study.
Clin Lymphoma Myeloma Leuk
; 15(7): 398-403, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25843416
18.
Patterns of relapse and outcome of elderly multiple myeloma patients treated as front-line therapy with novel agents combinations.
Leuk Res Rep
; 4(2): 64-9, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26500850
19.
First-line response-adapted treatment with the combination of bendamustine and rituximab in patients with mucosa-associated lymphoid tissue lymphoma (MALT2008-01): a multicentre, single-arm, phase 2 trial.
Lancet Haematol
; 1(3): e104-11, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27029228
20.
Rituximab for patients with idiopathic thrombocytopenic purpura.
Ann Intern Med
; 147(4): 281; author reply 281-2, 2007 Aug 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-17709765